Filing Details

Accession Number:
0001144204-11-020502
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-04-06 16:10:25
Reporting Period:
2011-04-04
Filing Date:
2011-04-06
Accepted Time:
2011-04-06 16:10:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1137883 Brainstorm Cell Therapeutics Inc BCLI Biological Products, (No Disgnostic Substances) (2836) 912061050
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1305117 S Malcolm Taub C/O Brainstorm Cell Therapeutics Inc.,
605 Third Avenue, 34Th Floor
New York NY 10158
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-04-04 6,500 $0.30 375,648 No 4 S Direct
Common Stock Disposition 2011-04-05 97,966 $0.30 277,682 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The transaction was executed in multiple trades at prices ranging from $0.30 to $0.31. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.